18F-fluorodeoxyglucose positron emission tomography/computed tomography (FDG-PET/CT) imaging in the staging and prognosis of inflammatory breast cancer
✍ Scribed by Jean-Louis Alberini; Florence Lerebours; Myriam Wartski; Emmanuelle Fourme; Elise Le Stanc; E. Gontier; O. Madar; P. Cherel; A. P. Pecking
- Publisher
- John Wiley and Sons
- Year
- 2009
- Tongue
- English
- Weight
- 310 KB
- Volume
- 115
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract ## BACKGROUND. Although studies comparing conventional imaging modalities with ^18^F‐fluorodeoxyglucose positron emission tomography (^18^F‐FDG‐PET) for the detection of lymphoma and although the relations between ^18^F‐FDG‐PET and histologic types were reported previously, most studie
## Abstract ## Background The aim of our study was to assess the value of positron emission tomography (PET) with 18F‐fluorodeoxyglucose (FDG) for the staging of clinically nodal negative necks in oral and oropharyngeal squamous cell carcinoma (SCC) using sentinel lymph node (SLN) biopsy and elect
## Abstract ## BACKGROUND To assess the ability of [^18^F]fluorodeoxyglucose (F‐18 FDG) positron emission tomography (PET) to predict the viability of residual masses after chemotherapy in patients with metastatic nonseminomatous germ cell tumors (GCT), PET results were compared in a blinded analy